Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oral Alpan

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Journal of Allergy and Clinical Immunology. in Practice|May 10, 2014
Diffuse cutaneous mastocytosis, bullous variant, presenting in a six-month-old infantLauren Kinneman, Barbara Molloy, Viet Nguyen, et al.
Pediatric Rheumatology Online Journal|June 27, 2018
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritisDaniel J Lovell, Jason A Dare, Megan Francis-Sedlak, et al.
Communications Biology|January 30, 2021
SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virusMikail Dogan, Lina Kozhaya, Lindsey Placek, et al.
Frontiers in Allergy|January 26, 2023
Towards an FDA-cleared basophil activation testOral Alpan, Richard L Wasserman, Theodore Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2020
Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19Mikail Dogan, Lina Kozhaya, Lindsey Placek, et al.
Allergy|May 16, 2021
Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVIDMatthew Plassmeyer, Oral Alpan, Michael J Corley, et al.
Cytometry. Part B, Clinical Cytometry|February 4, 2021
Validation of inducible basophil biomarkers: Time, temperature and transportationTheodore Kim, Jing Yu, Henry Li, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 13, 2020
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14Bruce K Patterson, Harish Seethamraju, Kush Dhody, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Journal of Allergy and Clinical Immunology. in Practice|May 10, 2014
Diffuse cutaneous mastocytosis, bullous variant, presenting in a six-month-old infantLauren Kinneman, Barbara Molloy, Viet Nguyen, et al.
Pediatric Rheumatology Online Journal|June 27, 2018
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritisDaniel J Lovell, Jason A Dare, Megan Francis-Sedlak, et al.
Communications Biology|January 30, 2021
SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virusMikail Dogan, Lina Kozhaya, Lindsey Placek, et al.
Frontiers in Allergy|January 26, 2023
Towards an FDA-cleared basophil activation testOral Alpan, Richard L Wasserman, Theodore Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2020
Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19Mikail Dogan, Lina Kozhaya, Lindsey Placek, et al.
Allergy|May 16, 2021
Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVIDMatthew Plassmeyer, Oral Alpan, Michael J Corley, et al.
Cytometry. Part B, Clinical Cytometry|February 4, 2021
Validation of inducible basophil biomarkers: Time, temperature and transportationTheodore Kim, Jing Yu, Henry Li, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 13, 2020
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14Bruce K Patterson, Harish Seethamraju, Kush Dhody, et al.
Pageof 4